NDC 85631-004 – Compound Oyster Peptide

Lycium Chinense Fruit 270 mg/1.2g; Asian Ginseng 180 mg/1.2g; Licorice 24 mg/1.2g; Polygonatum Sibiricum Whole 90 mg/1.2g; Phyllolobium Chinense Seed 72… · Capsule · Oral

Human Otc Drug

Product NDC85631-004

Product details

Brand name
Compound Oyster Peptide
Generic name
Compound Oyster Peptide
Labeler
Bispit Canada Ltd.
Dosage form
Capsule
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
August 3, 2025
Listing expires
December 31, 2026
Pharmacologic class
Copper Absorption Inhibitor; Non-Standardized Food Allergenic Extract

Active ingredients

Uses, dosage, side effects and warnings for Compound Oyster Peptide →

Package NDC codes (1)

Package NDCDescriptionSince
85631-004-0160 CAPSULE in 1 BOTTLE (85631-004-01) / 1.2 g in 1 CAPSULEAug 3, 2025